This is Grasshopper
With partners spanning Northern, Eastern, Western, and Southern Europe, as well as the United States, Australia, and Jordan, the consortium fosters a global exchange of knowledge and expertise. This international collaboration is essential to achieving clinical impact and ensuring equal access to cutting-edge therapies for all children with cancer.
Our Mission
Through this extensive multisectoral and multidisciplinary collaboration, GRASSHOPPER aims to accelerate pediatric oncology research, bridge the gap between discovery and clinical application, and provide equal access to cutting-edge treatments for children with cancer worldwide.
Our Partners: A Strong and Diverse Network
GRASSHOPPER is built on a multidisciplinary network of academic, clinical, and industry leaders, each contributing specialized expertise to drive innovation in pediatric oncology.
Leading European Academic Partners (Comprehensive Childhood Cancer Centers – CCCCs)
- Princess Máxima Center (NL)
- Institut Curie (FR)
- DKFZ-KiTZ (DE)
- Rigshospitalet (DK)
- FSJD-CERCA Pediatric Cancer Center Barcelona (ES)
- Aghia Sophia Children’s Hospital (GR)
- National Institute of Children’s Diseases (SK)
These centers specialize in clinical trial development and house some of Europe’s top research groups in preclinical and translational pediatric cancer research.
Global Academic Partners (CCCs outside Europe)
- Great Ormond St. Institute of Child Health, UCL (UK)
- Children’s Cancer Institute CCI (AU)
These internationally renowned institutions ensure that GRASSHOPPER’s research is embedded within a global framework, facilitating high-level staff exchanges.
National Leading Childhood Cancer Centers (NCCCs)
- Western Ukrainian Specialized Children’s Medical Center (UA)
- Children’s Clinical University Hospital BKUS (LV)
- Emergency Clinical Hospital for Children M.S. Curie (RO)
- King Hussein Cancer Center (JO)
These centers play a crucial role in expanding clinical trial research and initiating translational research, improving access to innovative treatments worldwide.
Industry Partners Driving Pediatric Drug Development
- Roche (CH)
- Sanofi (FR)
- Indiana Bioscience Research Institute (US)
These pharmaceutical leaders support pediatric drug development, focusing on repurposing adult cancer treatmentsand developing child-specific therapies.
Collaborative Networks for Training & Research
- ITCC (FR) – The leading European organization for early-phase clinical trials in pediatric oncology, supporting GRASSHOPPER’s training initiatives.
- Cancer Core Europe (CCE, FR) – A key partner focusing on adolescents and young adults (AYA) with cancer, strengthening the network’s patient-centered approach.
